Feifei Li joined INVO in February 2023. She is responsible for managing a technology portfolio in therapeutics and diagnostics. In her current role, she evaluates patentability and marketability, implements intellectual property strategies, negotiates licensing contracts, supports new venture creation, and promotes lab-to-launch and strategic partnerships.
Prior to joining INVO, she was a bioinorganic chemist, a tenure-track assistant professor at New Mexico State University, and an NIH-funded principal investigator. Feifei received her B.S. in chemistry from Nanjing University and her PhD in chemistry from the University of Minnesota – Twin Cities, followed by post-doctoral research at Brookhaven National Laboratory. Feifei is a registered patent agent with the USPTO.